ProMIS Neurosciences, Inc. (PMN) Misses Q2 EPS by 13c
Tweet
Share
E-mailGet Alerts PMN Hot Sheet
Join SI Premium – FREE
ProMIS Neurosciences, Inc. (NASDAQ: PMN) reported Q2 EPS of ($0.29), $0.13 worse than the analyst estimate of ($0.16).
For earnings history and earnings-related data on ProMIS Neurosciences, Inc. (PMN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- Barclays Upgrades Schott Pharma AG (1SXP:GR) to Overweight
- RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
